<DOC>
	<DOCNO>NCT01532375</DOCNO>
	<brief_summary>With epidemic obesity diabetes grow around world , Kochujang ( KCJ ) may potentially effective prevent treat obesity cardiovascular risk proven human . However , human trial still report KCJ supplementation . In present study , investigate hypothesis KCJ supplementation decrease body fat improve blood lipid profile overweight adult .</brief_summary>
	<brief_title>Kochujang , Fermented Soybean-based Red Pepper Paste , Decreases Visceral Fat Improves Blood Lipid Profiles Overweight Adults</brief_title>
	<detailed_description>The aim study evaluate efficacy KCJ supplementation anthropometric parameter , visceral fat/subcutaneous fat , blood lipid profile overweight subject . Sixty overweight subject BMI &gt; 25 kg/m2 waist-hip-ratio ( WHR ) ≥ 0.90 men ≥ 0.85 woman randomly assign either KCJ supplement ( n=30 , 32 g/day ) placebo ( n=30 , 32 g/day ) group 12 week .</detailed_description>
	<mesh_term>Overweight</mesh_term>
	<criteria>BMI &gt; 25kg/m2 2 ) WaistHip Ratio ( WHR ) : WHR &gt; 0.90 ( male ) , WHR &gt; 0.85 ( female ) lipid metabolic disorder &gt; 10 % change body weight past 3 month Cardiovascular disease arrhythmia , heart failure , myocardial infarction , wear pacemaker Allergy hypersensitivity ingredient test product History reaction experimental product gastrointestinal disease Crohn 's disease gastrointestinal surgery Participation clinical trial within past 2 month Abnormal hepatic liver function , renal disease acute chronic renal failure , nephrotic syndrome Use antipsychosis drug therapy within 2 month Laboratory test , medical psychological condition deem investigator interfere successful participation study History alcohol substance abuse Pregnancy breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Kochujang ,</keyword>
	<keyword>visceral fat</keyword>
	<keyword>population</keyword>
</DOC>